Gene knock-outs of inositol 1,4,5-trisphosphate receptors types 1 and 2 result in perturbation of cardiogenesis.
BACKGROUND
Inositol 1,4,5-trisphosphate receptors (IP3R1, 2, and 3) are intracellular Ca2+ release channels that regulate various vital processes. Although the ryanodine receptor type 2, another type of intracellular Ca2+ release channel, has been shown to play a role in embryonic cardiomyocytes, the functions of the IP3Rs in cardiogenesis remain unclear.


RESULTS
We found that IP3R1(-/-)-IP3R2(-/-) double-mutant mice died in utero with developmental defects of the ventricular myocardium and atrioventricular (AV) canal of the heart by embryonic day (E) 11.5, even though no cardiac defect was detectable in IP3R1(-/-) or IP3R2(-/-) single-mutant mice at this developmental stage. The double-mutant phenotype resembled that of mice deficient for calcineurin/NFATc signaling, and NFATc was inactive in embryonic hearts from the double knockout-mutant mice. The double mutation of IP3R1/R2 and pharmacologic inhibition of IP3Rs mimicked the phenotype of the AV valve defect that result from the inhibition of calcineurin, and it could be rescued by constitutively active calcineurin.


CONCLUSIONS
Our results suggest an essential role for IP3Rs in cardiogenesis in part through the regulation of calcineurin-NFAT signaling.
Uchida
Keiko
K
Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
Aramaki
Megumi
M
Nakazawa
Maki
M
Yamagishi
Chihiro
C
Makino
Shinji
S
Fukuda
Keiichi
K
Nakamura
Takeshi
T
Takahashi
Takao
T
Mikoshiba
Katsuhiko
K
Yamagishi
Hiroyuki
H
D000818:Animals; D049109:Cell Proliferation; D018507:Gene Expression Regulation, Developmental; D055786:Gene Knockout Techniques; D006321:Heart / Q000196:embryology*; D053496:Inositol 1,4,5-Trisphosphate Receptors / Q000235:genetics* / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D032383:Myocytes, Cardiac / Q000166:cytology / Q000378:metabolism; D015398:Signal Transduction
D053496:Inositol 1,4,5-Trisphosphate Receptors
J Biol Chem. 2003 Jan 17;278(3):1686-92
12427739
Mol Cell Biol. 2005 Dec;25(24):10979-88
16314520
Nature. 1998 Mar 12;392(6672):182-6
9515963
Cell. 2001 Jun 29;105(7):863-75
11439183
J Biochem. 1997 Sep;122(3):498-505
9348075
J Neurochem. 1988 Dec;51(6):1724-30
3141586
EMBO J. 1998 Jun 15;17(12):3309-16
9628868
J Biol Chem. 1994 Jun 17;269(24):16961-70
8207020
Mol Cell Biol. 2005 Aug;25(15):6649-59
16024800
Nature. 1996 Jan 11;379(6561):168-71
8538767
Nat Rev Mol Cell Biol. 2003 Jul;4(7):517-29
12838335
Nature. 1998 Mar 12;392(6672):186-90
9515964
Nat Biotechnol. 2005 May;23(5):607-11
15867910
Dev Biol. 1998 Apr 15;196(2):228-36
9576835
Cell. 2004 Sep 3;118(5):649-63
15339668
Dev Biol. 1989 Nov;136(1):118-28
2509260
Nature. 2002 May 16;417(6886):295-9
12015605
J Cell Biol. 1990 Dec;111(6 Pt 1):2427-36
2277065
J Mol Cell Cardiol. 2008 Aug;45(2):128-47
18603259
Cell. 2002 Apr;109 Suppl:S67-79
11983154
Trends Genet. 1995 Mar;11(3):87-93
7732578
FASEB J. 2002 Aug;16(10):1145-50
12153982
J Biol Chem. 2002 Mar 22;277(12):10704-11
11786533
FEBS Lett. 1994 Nov 7;354(2):149-54
7957915
Annu Rev Immunol. 2010;28:491-533
20307213
J Clin Invest. 2000 Feb;105(3):261-70
10675351
J Biol Chem. 2005 Mar 18;280(11):10305-17
15632133
Dev Biol. 1999 Feb 15;206(2):163-77
9986730
J Biol Chem. 2000 Mar 3;275(9):6417-20
10692444
Nature. 2006 Jun 1;441(7093):595-600
16554754
Am J Pathol. 1991 Jan;138(1):213-21
1987767
Nature. 1989 Nov 2;342(6245):32-8
2554142
Circ Res. 2003 Jun 27;92(12):1305-13
12750314
Science. 2005 Sep 30;309(5744):2232-4
16195467
Nature. 1992 Jun 25;357(6380):692-4
1377361
Dev Biol. 1999 Dec 1;216(1):72-84
10588864
Nature. 1999 Oct 14;401(6754):703-8
10537109